20-63689576-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001283009.2(RTEL1):​c.1953C>T​(p.Arg651Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00417 in 1,612,290 control chromosomes in the GnomAD database, including 255 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0053 ( 27 hom., cov: 33)
Exomes 𝑓: 0.0040 ( 228 hom. )

Consequence

RTEL1
NM_001283009.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0570

Publications

3 publications found
Variant links:
Genes affected
RTEL1 (HGNC:15888): (regulator of telomere elongation helicase 1) This gene encodes a DNA helicase which functions in the stability, protection and elongation of telomeres and interacts with proteins in the shelterin complex known to protect telomeres during DNA replication. Mutations in this gene have been associated with dyskeratosis congenita and Hoyerall-Hreidarsson syndrome. Read-through transcription of this gene into the neighboring downstream gene, which encodes tumor necrosis factor receptor superfamily, member 6b, generates a non-coding transcript. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2013]
RTEL1-TNFRSF6B (HGNC:44095): (RTEL1-TNFRSF6B readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring RTEL1 (regulator of telomere elongation helicase 1) and TNFRSF6B (tumor necrosis factor receptor superfamily, member 6b, decoy) genes on chromosome 20. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 20-63689576-C-T is Benign according to our data. Variant chr20-63689576-C-T is described in ClinVar as Benign. ClinVar VariationId is 473911.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.057 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0903 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RTEL1NM_001283009.2 linkc.1953C>T p.Arg651Arg synonymous_variant Exon 23 of 35 ENST00000360203.11 NP_001269938.1 Q9NZ71-6R4IXY3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTEL1ENST00000360203.11 linkc.1953C>T p.Arg651Arg synonymous_variant Exon 23 of 35 5 NM_001283009.2 ENSP00000353332.5 Q9NZ71-6
RTEL1ENST00000508582.7 linkc.2025C>T p.Arg675Arg synonymous_variant Exon 23 of 35 2 ENSP00000424307.2 Q9NZ71-7
RTEL1ENST00000370018.7 linkc.1953C>T p.Arg651Arg synonymous_variant Exon 23 of 35 1 ENSP00000359035.3 Q9NZ71-1
RTEL1-TNFRSF6BENST00000492259.6 linkn.2037C>T non_coding_transcript_exon_variant Exon 21 of 35 5 ENSP00000457428.1 D6RA96

Frequencies

GnomAD3 genomes
AF:
0.00528
AC:
803
AN:
152172
Hom.:
27
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0102
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.0971
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000691
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.0113
AC:
2804
AN:
248288
AF XY:
0.00953
show subpopulations
Gnomad AFR exome
AF:
0.00138
Gnomad AMR exome
AF:
0.0245
Gnomad ASJ exome
AF:
0.000606
Gnomad EAS exome
AF:
0.0946
Gnomad FIN exome
AF:
0.00145
Gnomad NFE exome
AF:
0.000636
Gnomad OTH exome
AF:
0.00711
GnomAD4 exome
AF:
0.00405
AC:
5913
AN:
1460000
Hom.:
228
Cov.:
32
AF XY:
0.00382
AC XY:
2777
AN XY:
726268
show subpopulations
African (AFR)
AF:
0.000836
AC:
28
AN:
33478
American (AMR)
AF:
0.0217
AC:
971
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
0.000498
AC:
13
AN:
26088
East Asian (EAS)
AF:
0.0979
AC:
3885
AN:
39690
South Asian (SAS)
AF:
0.00178
AC:
153
AN:
86186
European-Finnish (FIN)
AF:
0.00121
AC:
63
AN:
52070
Middle Eastern (MID)
AF:
0.00312
AC:
18
AN:
5766
European-Non Finnish (NFE)
AF:
0.000349
AC:
388
AN:
1111726
Other (OTH)
AF:
0.00653
AC:
394
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
320
640
960
1280
1600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00530
AC:
807
AN:
152290
Hom.:
27
Cov.:
33
AF XY:
0.00571
AC XY:
425
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00140
AC:
58
AN:
41564
American (AMR)
AF:
0.0105
AC:
160
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.0973
AC:
503
AN:
5168
South Asian (SAS)
AF:
0.00331
AC:
16
AN:
4828
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000691
AC:
47
AN:
68018
Other (OTH)
AF:
0.00379
AC:
8
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
34
69
103
138
172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00188
Hom.:
3
Bravo
AF:
0.00679
Asia WGS
AF:
0.0350
AC:
120
AN:
3478
EpiCase
AF:
0.000600
EpiControl
AF:
0.000297

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dyskeratosis congenita, autosomal recessive 5;C4225346:Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dyskeratosis congenita Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
7.2
DANN
Benign
0.95
PhyloP100
-0.057
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79210260; hg19: chr20-62320929; COSMIC: COSV58894581; COSMIC: COSV58894581; API